Cleared Traditional

K212473 - Welch Allyn Connex Central Station

K212473 is the FDA 510(k) clearance for Welch Allyn Connex Central Station by Welch Allyn, Inc.. It is a Class 2 Cardiovascular device (product code MWI) cleared through the Traditional 510(k) pathway after a 448-day FDA review.

K212473 · Welch Allyn, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2022
Decision
448d
Days
Class 2
Risk

K212473 is an FDA 510(k) clearance for the Welch Allyn Connex Central Station. Classified as Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms) (product code MWI), Class II - Special Controls.

Submitted by Welch Allyn, Inc. (Skaneateles Falls, US). The FDA issued a Cleared decision on October 28, 2022 after a review of 448 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2300 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Cardiovascular submissions.

View all Welch Allyn, Inc. devices

Submission Details

510(k) Number K212473 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 06, 2021
Decision Date October 28, 2022
Days to Decision 448 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
323d slower than avg
Panel avg: 125d · This submission: 448d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)

All 123
Devices cleared under the same product code (MWI) and FDA review panel - the closest regulatory comparables to K212473.
Radical-7 Pulse CO-Oximeter and Accessories, Rad-97 and Accessories
K212161 · Masimo Corporation · Mar 2023
VS 8 Vital Signs Monitor, VS 8A Vital Signs Monitor, VS 9 Vital Signs Monitor
K221267 · Shenzhen Mindray Bio-Meidcal Electronics Co., Ltd. · Dec 2022
Accutorr 3 Vital Signs Monitor, Rosebud Vital Signs Monitor
K221113 · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · Dec 2022
MedWand
K212975 · Medwand Solutions, Inc. · Jul 2022
Capsule Surveillance System
K213335 · Capsule Surveillance Technologies, Sas /Capsule Tech, Inc. · Jan 2022
Vital Signs Monitor
K211754 · Beijing Choice Electronic Technology Co., Ltd. · Nov 2021